Cargando…
SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year
In a SARS-CoV-2 seroprevalence study conducted with 1,655 working adults in spring of 2020, 12 of the subjects presented with positive neutralization test (NT) titers (>1:10). They were here followed up for 1 year to assess their Ab persistence. We report that 7/12 individuals (58%) had NT_50 tit...
Autores principales: | Garner-Spitzer, Erika, Wagner, Angelika, Kundi, Michael, Stockinger, Hannes, Ohradanova-Repic, Anna, Gebetsberger, Laura, Schoetta, Anna-Margarita, Gudipati, Venugopal, Huppa, Johannes B., Kunert, Renate, Mayrhofer, Patrick, Kreil, Thomas R., Farcet, Maria R., Hoeltl, Eva, Wiedermann, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885586/ https://www.ncbi.nlm.nih.gov/pubmed/35242786 http://dx.doi.org/10.3389/fmed.2022.822316 |
Ejemplares similares
-
Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.
por: Wagner, Angelika, et al.
Publicado: (2022) -
Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation
por: Garner-Spitzer, Erika, et al.
Publicado: (2023) -
Nomenclature of humanized mAbs: Early concepts, current challenges and future perspectives
por: Mayrhofer, Patrick, et al.
Publicado: (2018) -
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults
por: Wagner, Angelika, et al.
Publicado: (2021) -
Germinality does not necessarily define mAb expression and thermal stability
por: Schwaigerlehner, Linda, et al.
Publicado: (2019)